Pharmacokinetic and Pharmacodynamic Considerations in Drug Therapy of Cardiac Emergencies

Medicine & Life Sciences

• Emergencies 100%
• Pharmacokinetics 97%
• Drug Therapy 76%
• Pharmaceutical Preparations 53%
• Shock 31%
• Cardiopulmonary Resuscitation 14%
• Epinephrine 12%
• Lidocaine 9%
• Isoproterenol 9%
• Heart 8%
• Cardiac Output 8%
• Norepinephrine 7%
• bretylium 7%
• Brain 6%
• Procainamide 6%
• Dobutamine 5%
• Acute-Phase Proteins 5%
• Renal Circulation 5%
• Anti-Arrhythmia Agents 5%
• Vasoconstrictor Agents 4%
• Tissue Distribution 4%
• Verapamil 4%
• Nonesterified Fatty Acids 4%
• Atropine 4%
• Vasoconstriction 4%
• Propranolol 4%
• Protein Binding 4%
• Intravenous Infusions 4%
• Artifacts 4%
• Vascular Resistance 4%
• Intravenous Administration 4%
• Catecholamines 4%
• Heparin 4%
• Albumins 3%
• Glycoproteins 3%
• Dopamine 3%
• Lower Extremity 3%
• Acids 3%
• Central Nervous System 3%
• Homeostasis 3%
• Injections 2%
• Liver 2%
• Animals 2%
• In Vitro Techniques 1%
• Therapeutics 1%